Enzyme INtr, NPr and IIANtr Are Involved in Regulation of the Poly-β-Hydroxybutyrate Biosynthetic Genes in Azotobacter vinelandiiNoguez R.a · Segura D.a · Moreno S.a · Hernandez A.a · Juarez K.b · Espín G.a
Departamentos deaMicrobiología Molecular y bde Ingeniería Celular y Biocatálisis, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, Morelos, México
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
The ptsP, ptsO, and ptsN genes encode Enzyme INtr, NPr, and enzyme IIANtr (IIANtr) proteins of the nitrogen-related phosphotransferase system. These proteins participate in a phosphoryl transfer chain in several bacteria, where IIANtr appears to be the terminal phosphoryl acceptor. Inactivation of the ptsP gene in Azotobacter vinelandii was previously shown to reduce poly-β-hydroxybutyrate (PHB) production. Therefore, the question of a role of the ptsO and ptsN gene products in PHB synthesis was raised. In this work we constructed strains carrying mutations in the ptsO and ptsN genes and tested their effects on PHB accumulation. In the ptsO mutant, PHB accumulation diminished as in the ptsP mutant, while the ptsN mutant accumulated more PHB than the wild-type strain. The negative effects of the ptsP and ptsO mutations on PHB accumulation was suppressed by the ptsN mutation, and a H68A mutation in the phosphorylatable site of IIANtr, impaired PHB accumulation similar to the ptsP mutation. The ptsP and ptsO mutations negatively affected transcription of the phbBAC biosynthetic operon and of the phbR gene coding for a transcriptional activator of phbBAC, whereas the ptsN mutation increased expression of this operon. Taken together our data provide genetic evidence suggesting that the non-phosphorylated form of IIANtr is involved in negative regulation of phbR and phbBAC expression in A. vinelandii.
© 2007 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.